Former Utah Governor and Health and Human Services Secretary Michael Leavitt said the new administration will repeal President Obama’s Affordable Care Act by April. But that legislation will likely defer changes for 2 to 4 years. Leavitt outlines a five-phase process he believes will happen for Repeal 1.0 and then 2.0.
In the world of Epic founder and CEO Judy Faulkner, where creating new technology meets with a delight for words, 2016 was a productive and rewarding year. “We’re developing some really nifty new software,” she said after attending the daylong CHIME-HIMSS CIO Forum at HIMSS17. Learn more about Epic's two new EHR versions in development.
John Boehner, in an appearance with former Pennsylvania Governor Ed Rendell, says he's skeptical about the prospect of repeal-and-replace, because Republicans "will never, ever agree what the bill should be." Read more about their belief that IT is essential in the "affordability side of the equation."
IBM chief executive Ginni Rometty said that cognitive computing technologies could usher in a golden era for personalized and precision medicine. Learn more about what she believes are areas in healthcare ripe to benefit in 2017.
Today’s patients, like our current president, are immersed in social media, so it only makes sense that healthcare organizations should get on board too. But before you do, there are unique compliance hurdles that should be understood. Cardiologist and Fox News contributor Kevin Campbell, MD, and Michael Rutty, a legal subject matter expert from communications archiving company Actiance, explain what that means.
With the country adjusting to the new realities in Washington, Dan Rather gave attendees at the HX360 Executive Engagement Forum a perspective on the country’s future based on his years of reporting. His recommendation: Be optimistic.
Billionaire biotech mogul Patrick Soon-Shiong on Feb. 20 said the U.S. Food and Drug Administration has given his company the green light to advance his cancer vaccine into later stages of clinical trials. Learn more about the new vaccine and the company behind it.
